ESC Professional Premium Access

Plasma amyloid-beta levels and risk of new-onset atrial fibrillation in the general population

Congress Presentation

About the speaker

Doctor Zuolin Lu

Chinese Academy of Medical Sciences, Beijing (China)
0 follower

3 more presentations in this session

State of the art lecture - when is the time to implement novel biomarkers routinely?

Speaker: Professor B. Ference (Cambridge, GB)


Association of fatal and non-fatal adverse health outcomes with urinary peptides reflecting collagen I turnover

Speaker: Doctor J. Melgarejo (Leuven, BE)


Panel discussion.


Access the full session

When is the time to implement novel biomarkers routinely?

Speakers: Doctor Z. Lu, Professor B. Ference, Doctor J. Melgarejo

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb